Literature DB >> 14691921

Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor.

Motoko Sasaki1, Koichi Tsuneyama, Akira Ishikawa, Yasuni Nakanuma.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular and cholangiocarcinoma (HC-CC) are known to arise occasionally in hepatitis-related cirrhosis, although their clinicopathological features remain unclarified. In this study, we characterized the ICC (9 cases) and ICC elements of HC-CC (11 cases) arising in nonbiliary cirrhosis. Thirty-three hepatocellular carcinomas (HCC) associated with nonbiliary cirrhosis and 24 ICC without cirrhosis were used as controls. Prominent neutrophilic infiltration was frequent in ICC with cirrhosis (78%) and ICC elements of combined HC-CC (72%). Neutrophilic infiltration-related cytokines (interleukin 8, granulocyte colony-stimulating factor [G-CSF], and granulocyte macrophage colony-stimulating factor [GM-CSF]) were expressed frequently and intensely in carcinoma cells of ICC with cirrhosis (40%, 80%, and 60%, respectively) and in ICC elements of the combined one (13%, 38%, and 63%, respectively). Interleukin 8 was expressed in 18% of ICC without cirrhosis, irrespective of neutrophilic infiltration. Neutrophilic infiltration and expression of G-CSF and GM-CSF were in parallel (P < 0.05). G-CSF and GM-CSF mRNA were detected by RT-PCR in tissue specimens expressing G-CSF and GM-CSF at the protein level. Such neutrophilic infiltration and expression of G-CSF and GM-CSF were not evident in controls. The expressions of c-kit and c-Met, as a hematopoietic and hepatic stem cell marker, were seen frequently in ICC with cirrhosis (80% and 80%, respectively) and ICC elements of the combined one (63% and 50%, respectively). The present study revealed that the frequent expression of G-CSF and GM-CSF is a characteristic of ICC with cirrhosis and ICC in combined carcinoma, probably representing a phenotype of fetal hepatic parenchymal cell. The expression of these cytokines may be causally related to prominent neutrophilic infiltration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691921     DOI: 10.1016/j.humpath.2003.07.012

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.

Authors:  Yasuni Nakanuma; Yasunori Sato; Kenichi Harada; Motoko Sasaki; Jing Xu; Hiroko Ikeda
Journal:  World J Hepatol       Date:  2010-12-27

2.  Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.

Authors:  Chiara Raggi; Margherita Correnti; Antonio Sica; Jesper B Andersen; Vincenzo Cardinale; Domenico Alvaro; Giovanna Chiorino; Elisa Forti; Shannon Glaser; Gianfranco Alpini; Annarita Destro; Francesca Sozio; Luca Di Tommaso; Massimo Roncalli; Jesus M Banales; Cédric Coulouarn; Luis Bujanda; Guido Torzilli; Pietro Invernizzi
Journal:  J Hepatol       Date:  2016-09-01       Impact factor: 25.083

3.  Cholangiocellular carcinoma that produced both granulocyte-colony-stimulating factor and parathyroid hormone-related protein.

Authors:  Tetsuro Sohda; Hiroshi Shiga; Hidetoshi Nakane; Hiroshi Watanabe; Morishige Takeshita; Shotaro Sakisaka
Journal:  Int J Clin Oncol       Date:  2006-06       Impact factor: 3.402

4.  Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma.

Authors:  C Subimerb; S Pinlaor; V Lulitanond; N Khuntikeo; S Okada; M S McGrath; S Wongkham
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

5.  MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.

Authors:  Richard E Kast; Alex Alfieri; Hazem I Assi; Terry C Burns; Ashraf M Elyamany; Maria Gonzalez-Cao; Georg Karpel-Massler; Christine Marosi; Michael E Salacz; Iacopo Sardi; Pieter Van Vlierberghe; Mohamed S Zaghloul; Marc-Eric Halatsch
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

6.  An autopsy case of granulocyte-colony-stimulating-factor-producing extrahepatic bile duct carcinoma.

Authors:  Satoru Matsuyama; Tomonori Shimonishi; Hirofumi Yoshimura; Kensaku Higaki; Kenji Nasu; Mariko Toyooka; Shigehisa Aoki; Keiko Watanabe; Hajime Sugihara
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

7.  Primary localized malignant biphasic mesothelioma of the liver in a patient with asbestosis.

Authors:  Motoko Sasaki; Ichiro Araki; Toshiaki Yasui; Masaru Kinoshita; Keita Itatsu; Takayuki Nojima; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

8.  Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology.

Authors:  Ho Sung Park; Jun Sang Bae; Kyu Yun Jang; Ju Hyung Lee; Hee Chul Yu; Ji Hyeon Jung; Baik Hwan Cho; Myoung Ja Chung; Woo Sung Moon
Journal:  J Korean Med Sci       Date:  2011-07-27       Impact factor: 2.153

Review 9.  The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.

Authors:  Kurt Sartorius; Leo Swadling; Ping An; Julia Makarova; Cheryl Winkler; Anil Chuturgoon; Anna Kramvis
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.818

10.  Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway.

Authors:  Paweena Dana; Ryusho Kariya; Worachart Lert-Itthiporn; Wunchana Seubwai; Saowaluk Saisomboon; Chaisiri Wongkham; Seiji Okada; Sopit Wongkham; Kulthida Vaeteewoottacharn
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.